DHL Eyes Africa Growth With €500 Million Healthcare Supply Chain Investment

DHL Group has announced plans to invest €500 million in the healthcare supply chain across Africa and the Middle East over the next five years as part of its broader €2 billion global healthcare expansion initiative.

The move comes amid rising demand for pharmaceuticals on the continent and increasing Chinese investment in the region’s medical infrastructure.

The logistics giant disclosed that the investment will be focused on high-value, time-sensitive health services including the transportation and storage of vaccines, stem cells, cryogenic materials and insulin.

The expansion will also include investments in warehousing, packaging, and end-to-end supply-chain infrastructure.

Annette Naude, Head of Healthcare for DHL in the Europe, Middle East, and Africa (EMEA) region, confirmed the company’s strategic interest in Africa.

Speaking during an interview, she said: “We see America has come in and cut costs, but we do see other countries coming to the forefront and filling those gaps. Chinese investment in the region is really big.”

Naude noted that DHL’s operations in Africa and the Middle East are currently concentrated in South Africa, Egypt, Kenya, Dubai, and Saudi Arabia, with plans to scale up operations across emerging economies where pharmaceutical demand is accelerating.

According to data from Grand View Research, Africa’s pharmaceutical market is projected to generate $33.8 billion in revenue by 2030, driven by population growth, urbanization, and rising healthcare awareness.

DHL intends to capture a substantial share of this growing market through localized healthcare logistics solutions tailored to the continent’s infrastructure and regulatory dynamics.

The investment will prioritize the development of specialized warehouses capable of handling ultra-cold storage and serialization systems to ensure traceability of medicines and medical equipment from production to point-of-care delivery.

“When a doctor issues medicine at the bedside of a patient, he has to trust and rely on the network that medicine has been transported through,” Naude emphasized, highlighting the importance of supply chain integrity and temperature control.

DHL’s investment also aligns with growing partnerships between China and African governments in the healthcare sector. The company recently collaborated with Chinese stakeholders to build a medical devices facility in Kenya, which now exports healthcare equipment to the Middle East and Europe.

In addition to addressing persistent challenges such as malaria, the logistics firm sees opportunities in the growing demand for advanced therapies, including long-acting insulin formulations sourced from China. These innovations are being adopted by several African governments due to their convenience and improved patient outcomes.

The expansion reflects DHL’s long-term strategy of embedding healthcare logistics infrastructure in high-growth regions to support the global delivery of pharmaceuticals, medical technology, and life sciences products. The company’s global healthcare network currently includes more than 150 certified facilities.

The company reaffirmed its commitment to investing in local talent, regulatory compliance, and supply chain digitization to support scalable and reliable delivery of medical supplies across Africa and the Middle East.

With a clear focus on healthcare, traceability, and technological advancement, DHL is positioning itself as a critical enabler in Africa’s evolving health logistics ecosystem, leveraging both foreign and regional partnerships to build sustainable and resilient infrastructure.